Q Dong Selected Research

Q Dong Research Topics

Disease

18	Neoplasms (Cancer) 10/2019 - 02/2001
8	Neoplasm Metastasis (Metastasis) 09/2019 - 02/2001
4	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 05/2001
3	Infections 01/2023 - 11/2000
3	Carcinogenesis 07/2018 - 10/2012
3	Atherosclerosis 12/2015 - 09/2013
3	Obesity 12/2015 - 10/2001
3	Schizophrenia (Dementia Praecox) 02/2015 - 02/2013
3	Inflammation (Inflammations) 09/2013 - 03/2009
3	Insulin Resistance 05/2009 - 10/2001
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 07/2017
2	Fatty Liver 01/2023 - 03/2009
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 06/2022 - 02/2018
2	Hemorrhage 09/2021 - 06/2018
2	Wounds and Injuries (Trauma) 09/2021 - 02/2014
2	Breast Neoplasms (Breast Cancer) 08/2021 - 08/2017
2	Brain Injuries (Brain Injury) 08/2021 - 02/2014
2	Ischemic Stroke 01/2020 - 09/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 02/2018 - 12/2015
2	Hypoxia (Hypoxemia) 07/2017 - 12/2008
2	Hyperlipidemias (Hyperlipidemia) 06/2016 - 04/2011
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2016 - 01/2016
2	Neuroblastoma 12/2015 - 10/2015
2	Acute Promyelocytic Leukemia 10/2015 - 11/2001
2	Reperfusion Injury 01/2015 - 03/2014
2	Hemangioma (Angioma) 09/2014 - 10/2012
2	Cerebral Hemorrhage 02/2014 - 01/2008
2	Pre-Eclampsia (Preeclampsia) 01/2009 - 12/2008
1	Wilms Tumor (Wilm's Tumor) 02/2024
1	Parkinsonian Disorders (Parkinsonism) 11/2023
1	B-Cell Leukemia (Leukemia, B Cell) 10/2023
1	Lymphoma (Lymphomas) 10/2023
1	Chronic Hepatitis B 01/2023
1	Bacterial Infections (Bacterial Infection) 09/2021
1	Periodontitis 02/2021
1	Endocarditis 02/2020
1	Infarction (Infarctions) 01/2020
1	Stroke (Strokes) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2019
1	Hypertension (High Blood Pressure) 05/2019
1	Adenoma (Adenomas) 09/2017
1	Thrombocytopenia (Thrombopenia) 08/2017
1	Colonic Neoplasms (Colon Cancer) 03/2017

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 12/2016 - 08/2001
6	DNA (Deoxyribonucleic Acid)IBA 12/2015 - 11/2000
4	LipidsIBA 06/2022 - 04/2011
4	oxidized low density lipoproteinIBA 06/2022 - 04/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2021 - 02/2014
3	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 10/2001
3	LDL CholesterolIBA 06/2022 - 04/2011
3	Triglycerides (Triacylglycerol)IBA 05/2019 - 04/2011
3	Messenger RNA (mRNA)IBA 12/2016 - 05/2001
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2016 - 11/2013
3	CytokinesIBA 10/2001 - 05/2001
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2021 - 02/2014
2	Cytidine Triphosphate (CTP)IBA 01/2020 - 09/2014
2	MicroRNAs (MicroRNA)IBA 10/2019 - 07/2012
2	Protein Kinases (Protein Kinase)IBA 07/2018 - 07/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2018 - 04/2011
2	Lysine (L-Lysine)FDA Link 03/2017 - 06/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2015 - 03/2009
2	Complementary DNA (cDNA)IBA 03/2015 - 05/2001
2	Bosentan (Tracleer)FDA Link 01/2015 - 03/2014
2	Caspase 3 (Caspase-3)IBA 08/2014 - 01/2014
2	Phosphotransferases (Kinase)IBA 07/2014 - 01/2013
2	Calcium-Binding ProteinsIBA 09/2013 - 09/2001
2	Biomarkers (Surrogate Marker)IBA 09/2013 - 02/2013
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2013 - 10/2012
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2012 - 12/2001
2	FructoseIBA 05/2009 - 03/2009
2	Indicators and Reagents (Reagents)IBA 12/2001 - 02/2001
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2023
1	ApolipoproteinsIBA 10/2023
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2023
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2023
1	Fatty Acid ElongasesIBA 01/2023
1	Lipoproteins (Lipoprotein)IBA 06/2022
1	Biocompatible Materials (Biomaterials)IBA 09/2021
1	HydrogelsIBA 09/2021
1	Vancomycin FDA LinkGeneric 09/2021
1	Aquaporin 4IBA 08/2021
1	Macrophage Migration-Inhibitory FactorsIBA 02/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2020
1	Ku AutoantigenIBA 09/2019
1	Nonesterified Fatty Acids (NEFA)IBA 05/2019
1	MitogensIBA 07/2018
1	6-chloropenicillanic acid S-sulfoxideIBA 06/2018
1	IronIBA 09/2017
1	Capecitabine (Xeloda)FDA Link 08/2017
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2017
1	nasIBA 07/2017

Therapy/Procedure

8	Therapeutics 02/2020 - 04/2011
2	Ligation 01/2023 - 12/2015
2	Glycemic Control 05/2019 - 06/2015
2	Intraperitoneal Injections 07/2017 - 08/2014
1	Nephrectomy 02/2024
1	Adjuvant Chemotherapy 02/2024
1	Blood Component Removal (Apheresis) 06/2022
1	Radiotherapy 08/2021
1	Thrombectomy 01/2020